drug-resistance

Documents about drug-resistance

• A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.#830998ClinicalTrials.gov
• Whose Burden, Whose Benefit? Revisiting Ethical Trade-Offs in the WHO Guidelines on Scaling Up Mass Azithromycin Administration#277843Scholarly Commons at Boston University School of Law
• A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer#841252ClinicalTrials.gov
• Efflux and mecA/mecC-mediated-resistance in multi-drug-resistant Staphylococcus aureus clinical isolates from selected Ghanaian primary and tertiary hospitals: Efflux et résistance médiée par mecA/mecC chez des isolats cliniques de Staphylococcus aureus multirésistants provenant d'hôpitaux Ghanéens de soins primaires et tertiaires sélectionnés#317168African Journals Online
• AKR1C3 inhibitors and exploiters for the treatment and therapeutic monitoring of cancer: a patent review (2020-present).#425505PubMed
• Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer#849747ClinicalTrials.gov
• The frequency, risk factors, and complications of gastrointestinal dysfunction during enteral nutrition in critically ill patients#955303Koc University Digital Collections
• Long-Term Lamivudine Therapy for Chronic Hepatitis B#992464ClinicalTrials.gov
• Guideline on doxycycline post-exposure prophylaxis for sexually transmitted infections among men who have sex with men and transgender women#365977WHO IRIS
• Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact: web annex G: sampling, abstraction and reporting guidance for early warning indicators of HIV drug resistance#379677WHO IRIS
• Efficacy Study on Silver-coated ETT Cleaned With a Novel Device#875664ClinicalTrials.gov
• Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients#125893ClinicalTrials.gov
• All Pain, No GAIN: Need for Prudent Antimicrobial Use Provisions To Complement the GAIN Act#277837Scholarly Commons at Boston University School of Law
• Clínica y perfil de resistencia/sensibilidad en bacteriemias por bacilos Gram negativos no fermentadores en una unidad de cuidados intensivos pediátricos#619323DIALNET OAI Articles
• INTRINSIC AND SYSTEMIC REGULATION OF BRAF: UNCOVERING NEW REGULATION WITH NOVEL MUTATIONS AND MOUSE MODEL, ULTIMATELY ESTABLISHING NOVEL TARGETING SMALL MOLECULES#631198ScholarBank@NUS
• Molecular Characterization of Extended-Spectrum beta-Lactamase-Producer Klebsiella pneumoniae Isolates Causing Neonatal Sepsis in Peru#647585Repositorio Universidad Peruana Cayetano Heredia
• A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients#825782ClinicalTrials.gov
• Evaluation of the Variation of the Intestinal Microbiota and the Integrity of the Intestinal Barrier in Patients With M.D.R. Germ-induced Pneumonia Undergoing Enteral Nutrition#845360ClinicalTrials.gov
• Table 1_Synthesis of copper oxide nanoparticles using Aloe vera leaf extract and their antibacterial activity against methicillin-resistant Staphylococcus aureus and multi-drug resistant Klebsiella pneumoniae.docx#445423Figshare
• Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy#994228ClinicalTrials.gov
• A Clinical Trial of Resistant Potato Starch for Gut MDRO Decolonization#833734ClinicalTrials.gov
• Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae#883117ClinicalTrials.gov
• A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3#966461ClinicalTrials.gov
• Analytical validation of a metagenomic next-generation diagnostic platform for urinary tract infection in a Thai tertiary hospital setting: a BI-Biotia UTI cohort study.#669664eScholarship
• Analysis of drug binding pockets and repurposing opportunities for twelve essential enzymes of ESKAPE pathogens#491831eScholarship
• Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and Ecuador#900471ClinicalTrials.gov
• Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses#906665ClinicalTrials.gov
• Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda#996345eScholarship
• A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV#837760ClinicalTrials.gov
• Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus#912645ClinicalTrials.gov
• Prevalence of and factors associated with carbapenem resistant Enterobacterales rectal colonisation in hospitalised neonates in the Western Cape Province, South Africa#237322SUNScholar
• Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa#355831University of Pretoria Repository
• Supplementary materials for "<b>Genomic Insights into a Toxigenic </b><b><i>Vibrio cholerae</i></b><b> O139 Isolate Reveal Transmission Risk and Public Health Implications in a Low-Endemic Region</b>"#382006Figshare
• Rapport de situation sur la promotion de la mise en œuvre de l’approche « Une seule santé » dans la Région de la Méditerranée orientale [EM/RC73/INF.DOC.10]#638103WHO IRIS
• A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma#492031eScholarship
• Prevalence of New Delhi metallo-β-lactamase gene among multidrug-resistant Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates at the University College Hospital, Ibadan, Nigeria: Prévalence du gène de la métallo-β-lactamase New Delhi parmi les isolats cliniques d'Escherichia coli, Klebsiella pneumoniae et Pseudomonas aeruginosa multirésistants à l'Hôpital Universitaire d'Ibadan, au Nigéria#317170African Journals Online
• Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia#831980ClinicalTrials.gov